Published as part of the ACS Pharmacology & Translational Science special issue “Epigenetics 2022”. ACS Chemical Biology invites submissions that use chemical biology approaches or devise chemical biology tools to understand or exploit epigenetic modifications. ACS Chemical Neuroscience will focus on epigenetic mechanisms associated with neurogenesis and neural plasticity as well as cognition and memory. Papers of interest also include those aimed at neuropsychiatric disorders for which epigenetic deregulation is a key driver of the disease phenotype. ACS Infectious Diseases encourages manuscripts that investigate epigenetic mechanisms that can offer some insights toward the development of infectious diseases, by affecting the survival, replication, or infection capacity of the pathogen or the response from the host. Journal of Medicinal Chemistry encourages submissions across the full spectrum of epigenetics, including epigenetic studies focused on human and nonhuman species. ACS Medicinal Chemistry Letters will focus on advances in our understanding of chemical modulators of chromatin and RNA modifications and accept manuscripts in the form of Notes, Letters, Innovations, and Technology Notes. This article references 2 other publications.

中文翻译：

---

征文：“表观遗传学 2.0”——一个关于表观遗传学的联合虚拟特刊

作为ACS 药理学与转化科学特刊“表观遗传学 2022”的一部分发表。ACS Chemical Biology邀请使用化学生物学方法或设计化学生物学工具来理解或利用表观遗传修饰的提交。ACS 化学神经科学将专注于与神经发生和神经可塑性以及认知和记忆相关的表观遗传机制。感兴趣的论文还包括那些针对神经精神疾病的论文，其中表观遗传失调是疾病表型的关键驱动因素。ACS传染病鼓励研究表观遗传机制的手稿，这些机制可以通过影响病原体的存活、复制或感染能力或宿主的反应，为传染病的发展提供一些见解。Journal of Medicinal Chemistry鼓励所有表观遗传学领域的投稿，包括针对人类和非人类物种的表观遗传研究。ACS Medicinal Chemistry Letters将侧重于我们对染色质和 RNA 修饰的化学调节剂的理解的进展，并接受以注释、信件、创新和技术注释形式的手稿。本文引用了其他 2 篇出版物。